Related Experiment Video
Updated: Aug 12, 2026
Data Acquisition and Analysis In Brainstem Evoked Response Audiometry In Mice
Published on: May 10, 2019
Universal infant hearing screening by automated auditory brainstem response measurement
1Department of Audiology Services, Kaiser Permanente Medical Center, Honolulu, Hawaii 96819, USA.
Insights
Early identification of infant hearing loss through universal screening enables timely intervention. Prompt amplification before six months optimizes speech and language development in infants with bilateral hearing loss.
Area of Science:
- Pediatric audiology
- Neonatal screening
- Hearing loss intervention
Background:
- Identifying infants with permanent bilateral hearing loss is crucial.
- Early amplification before 6 months of age is a key intervention goal.
Purpose of the Study:
- To implement universal hearing screening for infants.
- To provide amplification for identified cases before 6 months of age.
Main Methods:
- A 5-year study involved 10,372 infants.
- Automated auditory brainstem response screening was conducted in nurseries.
- Diagnostic follow-up and outpatient testing were performed for infants who failed screening.
Main Results:
- 96% successful nursery screening; 4% failure rate.
- Incidence of bilateral hearing loss requiring amplification was 1.4/1000.
- Early amplification in well infants led to age-appropriate speech and language development.
Conclusions:
- Automated auditory brainstem response effectively identifies hearing loss in nurseries.
- Early identification and amplification optimize speech and language outcomes.
- This approach is effective for mild, moderate, and severe bilateral hearing loss.
Background:
Our purpose was to identify infants with a bilateral, permanent, handicapping hearing loss and to provide them with amplification before age 6 months.
Methodology:
The study population consisted of 10,372 infants born during a 5-year period. Universal hearing screening by automated auditory brainstem response was done in the nursery. Infants who failed the screening test were followed up diagnostically. Infants who were not tested in the nursery were followed up as outpatients. Hearing aids were recommended for those infants who had bilateral hearing loss.
Results:
Successful screening in the nursery was achieved for 96% of infants. The failure rate was 4%. The incidence of bilateral loss requiring amplification was 1.4/1000. The false-positive rate was 3.5% after the initial screening and .2% when a two-stage screening procedure was used. The incidence of congenital bilateral hearing loss in the well population was 1/1000, and in the neonatal intensive care unit population, 5/1000. The cost of screening was $17 per infant, and the cost to identify each true bilateral hearing loss was $17,750. Amplification was recommended for 15 infants; well infants who used hearing aids before age 6 months achieved age-appropriate speech and language development.
Conclusions:
Mild, moderate, and severe bilateral, persistent hearing loss can be identified in the nursery by automated auditory brainstem response measurement to provide amplification before age 6 months and thus optimize speech and language development.
